Evaluating blinatumomab implementation in low- and middle-income countries: a study protocol

BACKGROUND: The recent implementation of novel therapies has accelerated progress in pediatric cancer care. Despite the significantly poorer survival of patients in low- and middle-income countries (LMICs), administation complexities and other significant resource barriers have limited the translati...

Descripción completa

Detalles Bibliográficos
Autores principales: Duffy, Caitlyn, Santana, Victor, Inaba, Hiroto, Jeha, Sima, Pauley, Jennifer, Sniderman, Liz, Ghara, Niharendu, Mushtaq, Naureen, Narula, Gaurav, Bhakta, Nickhill, Rodriguez-Galindo, Carlos, Brandt, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187890/
https://www.ncbi.nlm.nih.gov/pubmed/35690878
http://dx.doi.org/10.1186/s43058-022-00310-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187890/
https://www.ncbi.nlm.nih.gov/pubmed/35690878
http://dx.doi.org/10.1186/s43058-022-00310-5

Ejemplares similares